Evaluation of microRNAs miR-196a, miR-30a-5P, and miR-490 as biomarkers of disease activity among patients with FSGS. - Wikidata - awgldk - TriplyDB

Evaluation of microRNAs miR-196a, miR-30a-5P, and miR-490 as biomarkers of disease activity among patients with FSGS.

Evaluation of microRNAs miR-196a, miR-30a-5P, and miR-490 as biomarkers of disease activity among patients with FSGS.

http://www.wikidata.org/entity/Q34124777

about

MiR-30a Inhibits the Epithelial--Mesenchymal Transition of Podocytes through Downregulation of NFATc3 Diabetic Nephropathy: Emerging Biomarkers for Risk Assessment.miRNAs in urine: a mirror image of kidney disease?MiR-196a Regulates High Glucose-Induced Mesangial Cell Hypertrophy by Targeting p27kip1.MicroRNA-30e targets BNIP3L to protect against aldosterone-induced podocyte apoptosis and mitochondrial dysfunction.Novel Biomarkers for Renal Diseases? None for the Moment (but One).Circulating microRNA-451 as a predictor of resistance to neoadjuvant chemotherapy in breast cancer.Primary focal segmental glomerulosclerosis: miRNAs and targeted therapies.MicroRNAs and drug-induced kidney injury.MicroRNAs as Master Regulators of Glomerular Function in Health and Disease.A comprehensive narrative review of diagnostic biomarkers in human primary membranous nephropathy.MiR-30a-5p Inhibits Epithelial-to-Mesenchymal Transition and Upregulates Expression of Tight Junction Protein Claudin-5 in Human Upper Tract Urothelial Carcinoma Cells Impact of Τh1 and Τh2 cytokines in the progression of idiopathic nephrotic syndrome due to focal segmental glomerulosclerosis and minimal change disease.Can biomarkers of disease activity guide treatment in FSGS?Understanding the Osteosarcoma Pathobiology: A Comparative Oncology Approach.Small non-coding RNA profiling in human biofluids and surrogate tissues from healthy individuals: description of the diverse and most represented species.Urinary miR-196a predicts disease progression in patients with chronic kidney disease.Con: Biomarkers in glomerular diseases: putting the cart before the wheel?Genome-wide Profiling of Urinary Extracellular Vesicle microRNAs Associated With Diabetic Nephropathy in Type 1 Diabetes.Urinary exosome miR-146a is a potential marker of albuminuria in essential hypertension

P2860

Q36247357-BE5790CC-3D37-445C-9A3A-1ED1C7C50152 Q36926187-E11376E4-BCE6-4043-8423-A741E9D5025F Q38347455-08F921F1-9B3C-425F-808D-2A6F524C2C69 Q38467126-373FC316-9193-4EF3-AE62-72931B30DC0F Q38726222-7B11EC05-13EA-4A11-BEE2-FB58E77B0DEE Q38763898-C4801F70-C3B0-48CB-95B1-9B0330FF160B Q38779495-4F699733-725C-4AF7-8377-078577DF3120 Q38804869-35BA87E0-382C-4B39-8FB3-817B0C4AF5B7 Q38820393-20489221-BC69-45E4-9F3B-DF7B54F4B0ED Q39148575-E6FD126A-4CBA-4526-9B27-93AC6A58EC9A Q40054212-2DA896EB-B99A-4572-992B-93F36E6850EC Q41574643-83EEF38E-4046-465F-8ABB-39F424DF26A2 Q42361928-30C96184-F993-41F8-9187-782A616B9F8B Q42858165-919D6D32-E26E-4093-9FC5-F26CCD5CE218 Q47132356-C2176203-A002-4E94-AFE1-FE8ECCBC8347 Q50105758-4CFA1E3C-8E63-4492-82C8-F59BE45B53DE Q52595649-E5589F38-D353-4FC0-850E-F95A64418056 Q53497916-116D60E4-6AA6-414C-8DAA-F8424C4577A3 Q55207759-05F0A4F6-00A1-44C4-BF2E-E69A7E9D954C Q58782695-3DD2E291-B249-484C-8F6F-ADDAF2785A2B

P2860

Evaluation of microRNAs miR-196a, miR-30a-5P, and miR-490 as biomarkers of disease activity among patients with FSGS.

http://www.wikidata.org/entity/Q34124777

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Evaluation of microRNAs miR-19 ...... vity among patients with FSGS.

@ast

Evaluation of microRNAs miR-19 ...... vity among patients with FSGS.

@en

Evaluation of microRNAs miR-19 ...... vity among patients with FSGS.

@nl

type

label

Evaluation of microRNAs miR-19 ...... vity among patients with FSGS.

@ast

Evaluation of microRNAs miR-19 ...... vity among patients with FSGS.

@en

Evaluation of microRNAs miR-19 ...... vity among patients with FSGS.

@nl

prefLabel

Evaluation of microRNAs miR-19 ...... vity among patients with FSGS.

@ast

Evaluation of microRNAs miR-19 ...... vity among patients with FSGS.

@en

Evaluation of microRNAs miR-19 ...... vity among patients with FSGS.

@nl

P1433

Q34124777-1BF01F20-983A-4602-B566-77B2F99D5B39

P1476

Q34124777-4F171D0C-784F-4401-82BA-8F57F7563DF5

P2093

Q34124777-0EBDC2C5-B480-49E1-A540-FCF4F1AB5C04

Q34124777-0F5724F7-AAD7-45F6-B5AC-2C4E11672A2B

Q34124777-1EF3AABB-DC8E-483A-AAAA-FCEB3A57FCF1

Q34124777-5099FBCC-E15E-49FB-BE85-1B2EE6F2DF9C

Q34124777-6126D36B-D662-4E88-B6B6-A084FD346B74

Q34124777-7DD38E64-D66F-4053-9D3D-26A65877D6E8

Q34124777-99E622A9-CF59-4F4A-BDAE-F5E596088BE3

Q34124777-BC9DB093-85CE-4390-85C4-2303D4018391

Q34124777-FC7F5CD4-CDE4-43BB-BFB0-C4A2B0361C8F

P2860

Q34124777-070B9145-8FE8-4AB9-9399-42796CDF9DA3

Q34124777-0AE45F8B-EC78-4A0D-8374-DBF832F2C674

Q34124777-111AC731-717C-4A8D-9081-4B6C3079F6A6

Q34124777-12CA0E24-E188-46B9-ACC6-2637F2B4B9E4

Q34124777-1D38EFF1-773B-4C2C-921E-45E3B0A00004

Q34124777-2766DD83-F2EF-4280-996B-BE48B89235AD

Q34124777-28E5D2F9-2B59-48F5-B203-7876598CCD15

Q34124777-33A93138-7FBF-4097-9FD6-7FEA6FAC9431

Q34124777-358DCCB0-36D4-49B7-A85C-B6D514E67EDE

Q34124777-365A25E1-9818-4960-8DB3-980D2C855A93

P304

Q34124777-CECBE7DA-8F6B-4141-AA47-7D2010CA0949

P31

Q34124777-A5ACD6D5-91BF-4061-B524-5958E4279E71

P356

Q34124777-F93D49AF-1A1B-472D-974B-1D9DFE7A10FF

P433

Q34124777-8201DE86-4B92-4D0C-BA52-3B475A2F4C2B

P478

Q34124777-07307A08-5685-4EBC-A74A-7A161D6BAF98

P577

Q34124777-07493F4F-854B-4752-8C23-0BF96CFCCA43

P5875

Q34124777-3819434F-2595-4DED-84D3-7175BBC59BAA

P698

Q34124777-C65F3AC6-B6CF-4ED9-B302-E4C6BE3D2F8C

P921

Q34124777-591FE5C2-5084-49CA-9249-31C5F740C404

Q34124777-6F7D693C-8349-4DA4-B3B5-3EC748113A28

P932

Q34124777-CF20A81C-02BB-412D-9C3F-70B0D01437ED

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Evaluation of microRNAs miR-19 ...... vity among patients with FSGS.

@en

P2093

Changming Zhang

http://www.w3.org/2001/XMLSchema#string

Chunbei Liu

http://www.w3.org/2001/XMLSchema#string

Huimei Chen

http://www.w3.org/2001/XMLSchema#string

Ke Zen

http://www.w3.org/2001/XMLSchema#string

Limin Li

http://www.w3.org/2001/XMLSchema#string

Shaolin Shi

http://www.w3.org/2001/XMLSchema#string

Wanfen Zhang

http://www.w3.org/2001/XMLSchema#string

Yuanmao Tu

http://www.w3.org/2001/XMLSchema#string

Zhihong Liu

http://www.w3.org/2001/XMLSchema#string

P2860

miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice

Characterization of extracellular circulating microRNA

Exosomes from human saliva as a source of microRNA biomarkers

MicroRNA-196: critical roles and clinical applications in development and cancer

Nephrotic syndrome in adults

Circulating microRNAs as stable blood-based markers for cancer detection.

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

MicroRNAs: genomics, biogenesis, mechanism, and function

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

Causes and consequences of microRNA dysregulation in cancer

P304

1545-1552

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.11561113

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267749371

http://www.w3.org/2001/XMLSchema#string

P698

25107948

http://www.w3.org/2001/XMLSchema#string

P921

P932

4152819

http://www.w3.org/2001/XMLSchema#string